The European Union’s consumer watchdogs are probing nine video-game publishers, among them Sweden’s King and Mojang, to examine how virtual currencies are used in their games and whether they comply with EU consumer protection rules.
AnimaWings confirmed that it has started a judicial reorganization to address technical fleet issues and rising operating costs, while continuing to operate flights and urging passengers to check their booking status.
Cohere’s chief AI officer warned that without developing AI capabilities locally in Europe, the company could be squeezed by US and Chinese pressures, underscoring the strategic importance of European AI infrastructure for the startup.
Dutch price comparison platform Beslist.nl reports a noticeable drop in organic traffic after Google changed its Shopping results to comply with the EU Digital Markets Act, reducing the visibility of price comparers.
Tip Top Food Industry SRL, operator of the Tip Top pastry chain, was fined €5,000 by the National Authority for the Supervision of Personal Data Processing (ANSPDCP) for processing biometric fingerprint data of its employees for attendance tracking without a legal basis, violating GDPR articles 5 and 9. The authority also ordered the company to replace the biometric system with a non‑intrusive alternative.
OpenAI, the U.S. artificial‑intelligence startup, did not submit the required notification to the EU AI Office about a large‑scale AI‑bot intrusion affecting Hugging Face, violating the reporting obligations of the EU AI Act. The article notes uncertainty about whether OpenAI reported six other incidents it later disclosed, which it described as unexpected or concerning model behaviour.
Swedish price‑comparison startup Prisjakt has filed a lawsuit against Google, seeking more than SEK 21 billion in damages following a recent court victory by its rival Pricerunner against the tech giant.
Aiom is urging US biotech company Revolution Medicines to launch a compassionate‑use program for daraxonrasib, a targeted therapy that has doubled survival in a pancreatic cancer trial. While the drug received FDA approval in the United States, no similar early‑access program exists in Europe, and Revolution Medicines has not submitted a registration dossier to the European Medicines Agency. Aiom and Italian oncologists argue the drug should be provided free of charge to Italian patients pending approval, citing ethical concerns over high import costs.
Anyfin cut its net loss by over 100 million SEK and obtained a Swedish bank licence, enabling it to finance its lending via savings accounts and nearly halve its financing costs.
Romanian mattress retailer Dormeo Home SRL was fined €2,000 by the National Authority for the Supervision of Personal Data Processing (ANSPDCP) after an investigation found the company continued to send marketing SMS and phone calls despite a consumer exercising their right to object, violating GDPR provisions.